Semaglutide is an injectable prescription medicine that has changed the way many people manage weight
Semaglutide is not contraindicated in inflammatory bowel disease, but patients with ulcerative colitis or Crohn's disease should discuss their condition with their healthcare provider before starting treatment
The company is developing an innovative, painless microneedle obesity treatment that can be applied weekly to the arms or abdomen, delivering medication directly through the microvasculature, offering a convenient alternative to traditional, injectable GLP-1 analogue therapies
Tirzepatide, despite its strength, doesnt necessarily entail a higher risk of these rare, severe side effects
Patients should seek emergency care for symptoms of severe hypertension, including severe headache, chest pain, neurologic deficits, or shortness of breath with very high blood pressure
conducted a retrospective cohort study with data spanning more than 5year followup period with patients with T2DM or obesity